We are live on ! Find out more
FUSN

Fusion Pharmaceuticals Inc. Common Shares
FUSN

Delisted

FUSN was delisted on the 3rd of June, 2024.

Back to rankings

37 hedge funds and large institutions have $320M invested in Fusion Pharmaceuticals Inc. Common Shares in 2020 Q4 according to their latest regulatory filings, with 11 funds opening new positions, 8 increasing their positions, 8 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

267% more first-time investments, than exits

New positions opened: 11 | Existing positions closed: 3

50% more funds holding in top 10

Funds holding in top 10: 2 → 3 (+1)

28% more funds holding

Funds holding: 29 → 37 (+8)

5% more capital invested

Capital invested by funds: $304M → $320M (+$16M)

0% more repeat investments, than reductions

Existing positions increased: 8 | Existing positions reduced: 8

Holders
37
Holders Change
+8
Holders Change %
+27.59%
% of All Funds
0.65%
Holding in Top 10
3
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+50%
% of All Funds
0.05%
New
11
Increased
8
Reduced
8
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Point72 Asset Management
Point72 Asset Management
Connecticut
+$6.91M
2
BlackRock
BlackRock
New York
+$4.66M
3
SCM
Sio Capital Management
New York
+$2.17M
4
Vanguard Group
Vanguard Group
Pennsylvania
+$447K
5
Victory Capital Management
Victory Capital Management
Texas
+$351K

Top Sellers

Rank Fund Capital Flow
1
DM
Deerfield Management
New York
-$10.2M
2
FCM
Farallon Capital Management
California
-$2.25M
3
Millennium Management
Millennium Management
New York
-$1.71M
4
AllianceBernstein
AllianceBernstein
Tennessee
-$444K
5
CCM
CAAS Capital Management
New York
-$443K
Name Holding Trade Value Shares
Change 		Change in
Stake
JJIJ
1
Johnson & Johnson Innovation - JJDC
New Jersey
$43.1M – – –
ASP
2
Adams Street Partners
Illinois
$41M -$122K -9,676 -0.3%
O
3
OrbiMed
New York
$37.9M – – –
Fidelity Investments
4
Fidelity Investments
Massachusetts
$36.8M +$58.2K +4,631 +0.1%
Canada Pension Plan Investment Board
5
Canada Pension Plan Investment Board
Ontario, Canada
$36.6M – – –
TGHSA
6
TPG Group Holdings (SBS) Advisors
Texas
$30M – – –
PA
7
Perceptive Advisors
New York
$26.3M – – –
PBPIA
8
Pivotal bioVenture Partners Investment Advisor
California
$18.8M +$20.1M +1,598,379 New
RSCM
9
Rock Springs Capital Management
Maryland
$11.1M +$9.87K +786 +0.1%
BlackRock
10
BlackRock
New York
$9.76M +$4.66M +370,819 +81%
Point72 Asset Management
11
Point72 Asset Management
Connecticut
$6.46M +$6.91M +550,000 New
Federated Hermes
12
Federated Hermes
Pennsylvania
$6.17M +$188K +15,000 +3%
CCP
13
Clough Capital Partners
Massachusetts
$4.69M -$42.7K -3,401 -0.8%
Victory Capital Management
14
Victory Capital Management
Texas
$2.11M +$351K +27,916 +18%
SCM
15
Sio Capital Management
New York
$2.03M +$2.17M +172,693 New
DM
16
Deerfield Management
New York
$1.91M -$10.2M -809,668 -83%
Alyeska Investment Group
17
Alyeska Investment Group
Illinois
$881K -$7.54K -600 -0.8%
WP
18
Woodline Partners
California
$621K -$292K -23,266 -31%
Norges Bank
19
Norges Bank
Norway
$588K – – –
Millennium Management
20
Millennium Management
New York
$546K -$1.71M -136,202 -75%
Morgan Stanley
21
Morgan Stanley
New York
$469K +$167K +13,258 +50%
SFI
22
Susquehanna Fundamental Investments
Pennsylvania
$445K -$23.8K -1,894 -5%
Vanguard Group
23
Vanguard Group
Pennsylvania
$418K +$447K +35,588 New
CCM
24
CAAS Capital Management
New York
$272K -$443K -35,250 -60%
Geode Capital Management
25
Geode Capital Management
Massachusetts
$271K – – –
1
2

FUSN Hedge Fund Activity: Q4 2020 in Review

37 of the 5,651 institutional investors tracked by Wall St. Rank reported a position in Fusion Pharmaceuticals Inc. Common Shares (FUSN) for Q4 2020, worth a combined $320M — up 5.2% from $304M a quarter earlier.

Buyers outnumbered sellers: 11 funds opened new FUSN positions and 3 closed out — a net gain of 8 holders — while 8 added to existing stakes and 8 trimmed.

The largest buyer was Point72 Asset Management, opening a new position worth an estimated $6.91M. The largest seller was Deerfield Management, cutting an estimated $10.2M.

  • 37 institutional investors held Fusion Pharmaceuticals Inc. Common Shares (FUSN) as of Q4 2020, up from 29 in Q3 2020.
  • Funds reported $320M of Fusion Pharmaceuticals Inc. Common Shares stock for Q4 2020, up 5.2% quarter-over-quarter.
  • 11 funds opened new Fusion Pharmaceuticals Inc. Common Shares positions in Q4 2020 and 3 closed out, a net change of +8 holders.
  • The largest Fusion Pharmaceuticals Inc. Common Shares buyer in Q4 2020 was Point72 Asset Management, an estimated $6.91M added.
  • The largest Fusion Pharmaceuticals Inc. Common Shares seller in Q4 2020 was Deerfield Management, an estimated $10.2M sold.

Based on aggregated 13F filings for Q4 2020.